Home
About
Overview
Sharing Data
ORCID
Help
History (1)
The eIF4E inhibitor ribavirin as a potential antilymphoma therapeutic: early clinical data
.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
The eIF4E inhibitor ribavirin as a potential antilymphoma therapeutic: early clinical data
.
The eIF4E inhibitor ribavirin as a potential antilymphoma therapeutic: early clinical data
. Leuk Lymphoma. 2018 01; 59(1):256-258.
View in:
PubMed
subject areas
Antiviral Agents
Eukaryotic Initiation Factor-4E
Humans
Lymphoma
Remission Induction
Respiratory Syncytial Virus Infections
Respiratory Syncytial Viruses
Retrospective Studies
Ribavirin
authors with profiles
Koen Van Besien